financetom
Business
financetom
/
Business
/
Bio-Techne Fiscal Q1 Adjusted Earnings, Net Sales Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bio-Techne Fiscal Q1 Adjusted Earnings, Net Sales Rise
Nov 3, 2024 2:54 PM

07:41 AM EDT, 10/30/2024 (MT Newswires) -- Bio-Techne ( TECH ) reported fiscal Q1 adjusted earnings Wednesday of $0.42 per diluted share, up from $0.41 a year earlier.

Analysts polled by Capital IQ expected $0.38.

Net sales for the quarter ended Sept. 30 were $289.5 million, up from $276.9 million a year earlier.

Analysts surveyed by Capital IQ expected $280.1 million.

Separately, the company maintained its quarterly dividend at $0.08 per share, payable Nov. 22 to shareholders of record on Nov. 11.

Shares of the company rose 4.6% in recent premarket activity.

Price: 73.99, Change: +3.25, Percent Change: +4.59

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Banks behind troubled Brazil coffee traders could take $181 million hit
Banks behind troubled Brazil coffee traders could take $181 million hit
Dec 2, 2024
(Reuters) - Banks which financed two Brazilian coffee traders that last week sought court-supervised debt restructuring have a total of 1.1 billion reais ($181.6 million) in credit with the firms, court documents seen by Reuters showed on Monday. The amount refers only to advance money the banks gave to traders Atlantica and Cafebras in contracts linked to future coffee exports,...
Applied Therapeutics says it received FDA's warning letter for genetic disease drug study
Applied Therapeutics says it received FDA's warning letter for genetic disease drug study
Dec 2, 2024
Dec 2 (Reuters) - Applied Therapeutics ( APLT ) said on Monday it received a warning letter limited to a trial studying its genetic disease drug, after the U.S. health regulator declined to approve the treatment last week. ...
Pershing Square to delist from Euronext Amsterdam
Pershing Square to delist from Euronext Amsterdam
Dec 2, 2024
(Reuters) - Pershing Square Holdings said on Monday it plans to delist its shares from Euronext Amsterdam, after billionaire Bill Ackman urged its board last month. The investment holding company, in which Ackman and his family own a 23% stake, said its shares will continue to be traded in dollars and pounds on the main market of the London Stock...
Honeywell lowers sales, profit forecasts after Bombardier agreement
Honeywell lowers sales, profit forecasts after Bombardier agreement
Dec 2, 2024
(Reuters) - Honeywell ( HON ) on Monday cut its profit and sales forecasts for the fourth quarter and the full year to take into account investments associated with an agreement to provide aviation-related technology for Bombardier's aircraft. Honeywell's ( HON ) shares fell about 2% to $226 after the bell. The agreement will provide Honeywell's ( HON ) avionics,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved